Nuzenio

Bladder Business Wire

Bladder Business Wire entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Summit Therapeutics Further Expands Ivonescimab Global Development Program with Phase II/III HARMONi-GU1 Study in 1L Bladder Cancer - Business WireBusiness Wire · Wed, 05 Aug 2026 11:00:00 GMTenGene to Host Virtual KOL Event to Discuss Emerging Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, on August 11, 2026 - Business WireBusiness Wire · Tue, 04 Aug 2026 12:00:00 GMTMonroe Capital Supports Summit Professional Education’s Acquisition of Kids Bowel & Bladder - Business WireBusiness Wire · Tue, 04 Aug 2026 10:00:00 GMTLantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Business WireBusiness Wire · Tue, 28 Jul 2026 11:45:00 GMT

Timeline

Wed, 05 Aug 2026 11:00:00 GMTSummit Therapeutics Further Expands Ivonescimab Global Development Program with Phase II/III HARMONi-GU1 Study in 1L Bladder Cancer - Business Wire
Tue, 04 Aug 2026 12:00:00 GMTenGene to Host Virtual KOL Event to Discuss Emerging Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, on August 11, 2026 - Business Wire
Tue, 04 Aug 2026 10:00:00 GMTMonroe Capital Supports Summit Professional Education’s Acquisition of Kids Bowel & Bladder - Business Wire
Tue, 28 Jul 2026 11:45:00 GMTLantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Bladder Business Wire.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.